NCT04186585View on ClinicalTrials.gov

Recommended Dose Estimation of BP-C2

PHASE1RecruitingINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

August 1, 2025

Study Completion Date

September 30, 2025

Conditions

Prostate Cancer

Interventions

DRUG

BP-C2

Oral daily intake

Trial Locations (1)

2013

RECRUITING

Meddoc, Skjetten

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Meabco A/S

INDUSTRY

lead

Meddoc

OTHER

NCT04186585 - Recommended Dose Estimation of BP-C2 | Biotech Hunter | Biotech Hunter